Yesin a study published in Endocrine Practice, people who switched directly from a GLP-1 treatment (including semaglutide) to tirzepatide at 5 mg saw improved blood sugar control and additional weight loss within 12 weeks, with milder digestive side effects that typically seen in patients starting tirzepatide for the first time
Those who suffer from fine lines or wrinkles and want to improve skin elasticity
Consequently, since it is formed constitutively in the gastric mucosa, stable, and present in human gastric juice (Sikiric et al., 1993
After 17 months on the medication, Dunham transitioned to what she described as a maintenance dose, which she continues to take every 10 to 14 days
Participants had notable weight loss over 72 weeks, highlighting the drugs potential to provide substantial benefits in managing chronic weight issues